Factor 8 and Factor 9 Deficient Plasmas
Factor-8 and Factor-9 Deficient Plasmas
Helena’s high-quality factor deficient plasmas are trusted worldwide by pharmaceutical and government customers, offering a reliable method for the quality control of haemophilia treatment products.
- Congenitally deficient plasmas ensure presence of naturally associated proteins (for example Von Willebrand Factor)
- Provides more accurate factor deficiency clotting time
- Residual factor activity of less than 1%
- Available guaranteed HiV and Hepatitis-negative
- Long-term shelf life and stability
Factor VIII and Factor IX Deficient Plasmas are widely used for the quality control of Haemophilia A and Haemophilia B treatment products. Our congenital plasmas are sourced from naturally-deficient human donors and do not suffer from the removal of other proteins which can occur with immunodepleted products.
Helena Biosciences offer a full range of Factor Deficient Plasmas in both congenital and immunodepleted formats, and our plasmas are available as guaranteed HIV and Hepatitis-negative.
Technical details
The intrinsic factor deficient plasmas are intended for the quantitative determination of specific factor activity in citrated human plasma. This one-stage method requires an appropriate APTT reagent and any instrument capable of performing APTT-based factor assay testing.
Kit contents
Factor 8 Deficient Plasmas:
|
Component |
REF |
Volume |
|---|---|---|
|
Factor VIII Deficient Plasma (Congenital) |
5193 |
10 × 1 mL |
|
Factor VIII Deficient Plasma (Immunodepleted) |
5793 |
10 × 1 mL |
Factor 9 Deficient Plasmas:
|
Component |
REF |
Volume |
|---|---|---|
|
Factor IX Deficient Plasma (Congenital) |
5194 |
10 × 1 mL |
|
Factor IX Deficient Plasma (Immunodepleted) |
5794 |
10 × 1 mL |
Key: Liquid Lyophilised
More information
Contact me about this
Leave your details using this quick form and we will get in touch.
Haemostasis assays 
Instruments 
